125 related articles for article (PubMed ID: 38096027)
1. Differences in respiratory function, depressive symptoms and quality of life between patients with hereditary motor and sensory neuropathy and myotonic dystrophy undergoing maintenance rehabilitation.
Lajlar N; Vidmar G; Moharić M
Int J Rehabil Res; 2024 Mar; 47(1):20-25. PubMed ID: 38096027
[TBL] [Abstract][Full Text] [Related]
2. Respiratory muscle training in children and adults with neuromuscular disease.
Silva IS; Pedrosa R; Azevedo IG; Forbes AM; Fregonezi GA; Dourado Junior ME; Lima SR; Ferreira GM
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011711. PubMed ID: 31487757
[TBL] [Abstract][Full Text] [Related]
3. Influence of relatives on fatigue experienced by patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I.
Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
Eur Neurol; 2006; 56(1):24-30. PubMed ID: 16914927
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I.
Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
Acta Neurol Scand; 2007 Apr; 115(4):265-70. PubMed ID: 17376125
[TBL] [Abstract][Full Text] [Related]
5. Respiratory muscle strength and quality of life in myotonic dystrophy patients.
Araújo TL; Resqueti VR; Bruno S; Azevedo IG; Dourado ME; Fregonezi G
Rev Port Pneumol; 2010; 16(6):892-8. PubMed ID: 21067695
[TBL] [Abstract][Full Text] [Related]
6. Profiles of neuromuscular diseases. Hereditary motor and sensory neuropathy, types I and II.
Carter GT; Abresch RT; Fowler WM; Johnson ER; Kilmer DD; McDonald CM
Am J Phys Med Rehabil; 1995; 74(5 Suppl):S140-9. PubMed ID: 7576421
[TBL] [Abstract][Full Text] [Related]
7. Respiratory muscle training for multiple sclerosis.
Rietberg MB; Veerbeek JM; Gosselink R; Kwakkel G; van Wegen EE
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD009424. PubMed ID: 29267988
[TBL] [Abstract][Full Text] [Related]
8. Employment status of patients with neuromuscular diseases in relation to personal factors, fatigue and health status: a secondary analysis.
Minis MA; Kalkman JS; Akkermans RP; Engels JA; Huijbregts PA; Bleijenberg G; Oostendorp RA; van Engelen BG
J Rehabil Med; 2010 Jan; 42(1):60-5. PubMed ID: 20111846
[TBL] [Abstract][Full Text] [Related]
9. [The rate of free-radical oxidation in hereditary motor-sensor neuropathies and myotonic dystrophy].
Saĭfullina EV; Magzhanov RV; Farkhutdinov RR
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11):46-8. PubMed ID: 23257746
[TBL] [Abstract][Full Text] [Related]
10. Genetic linkage with chromosome 19 but not chromosome 17 in a family with myotonic dystrophy associated with hereditary motor and sensory neuropathy.
Brunner HG; Spaans F; Smeets HJ; Coerwinkel-Driessen M; Hulsebos T; Wieringa B; Ropers HH
Neurology; 1991 Jan; 41(1):80-4. PubMed ID: 1985299
[TBL] [Abstract][Full Text] [Related]
11. Deterioration of motor function in myotonic dystrophy and hereditary motor and sensory neuropathy.
Lindeman E; Leffers P; Spaans F; Drukker J; Reulen J
Scand J Rehabil Med; 1995 Mar; 27(1):59-64. PubMed ID: 7792552
[TBL] [Abstract][Full Text] [Related]
12. The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
J Psychosom Res; 2007 May; 62(5):571-9. PubMed ID: 17467412
[TBL] [Abstract][Full Text] [Related]
13. Rehabilitation interventions for foot drop in neuromuscular disease.
Sackley C; Disler PB; Turner-Stokes L; Wade DT; Brittle N; Hoppitt T
Cochrane Database Syst Rev; 2009 Jul; (3):CD003908. PubMed ID: 19588347
[TBL] [Abstract][Full Text] [Related]
14. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial.
Lindeman E; Leffers P; Spaans F; Drukker J; Reulen J; Kerckhoffs M; Köke A
Arch Phys Med Rehabil; 1995 Jul; 76(7):612-20. PubMed ID: 7605179
[TBL] [Abstract][Full Text] [Related]
15. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary rehabilitation for chronic obstructive pulmonary disease.
McCarthy B; Casey D; Devane D; Murphy K; Murphy E; Lacasse Y
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD003793. PubMed ID: 25705944
[TBL] [Abstract][Full Text] [Related]
17. Respiratory function in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a 1.5-year natural history study.
Bouman K; van Doorn JLM; Groothuis JT; Wijkstra PJ; van Engelen BGM; Erasmus CE; Doorduin J; Voermans NC
Eur J Paediatr Neurol; 2024 Jan; 48():30-39. PubMed ID: 38008001
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary function in patients with hereditary motor and sensory neuropathy: a comparison of patients with and without spinal deformity.
Horacek O; Chlumsky J; Mazanec R; Kolar P; Andel R; Kobesova A
Neuromuscul Disord; 2012 Dec; 22(12):1083-9. PubMed ID: 22727686
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
[TBL] [Abstract][Full Text] [Related]
20. [Survey of patients with advanced-stage Okinawa-type neurogenic muscular atrophy (hereditary motor and sensory neuropathy with proximal dominant involvement: HMSN-P)].
Taniguchi M; Yorishima Y; Shoji H; Ide M; Kumura Y; Kunisaki K
Rinsho Shinkeigaku; 2022 Feb; 62(2):152-156. PubMed ID: 35095044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
